🇺🇸 FDA

Company profile · Sponsor

Yung

Yung NA

C2ABC21 · NMPA pharma CN
Pipeline
10
Drugs
0
Patents
0

Quick answer

Yung (C2ABC21) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C2ABC21
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (10)

Search pipeline →

  1. Fimasartan and Rosuvastatin

    Yung

    Essential Hypertension, Dyslipidemia

    phase 3 small molecule completed

    1 trial

  2. dabigatran

    Yung

    Atrial Fibrillation

    phase 3 small molecule active

    1 trial

  3. Prednisone + Jakavi(ruxolitinib)

    Yung

    GVHD - Graft-Versus-Host Disease

    phase 2 small molecule active

    1 trial

  4. gemcitabine

    Yung

    Muscle Invasive Bladder Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  5. BRI-1501

    Yung

    Gastric Ulcer

    phase 1 small molecule completed

    1 trial

  6. Fimasartan

    Yung

    Hypertension

    phase 1 small molecule completed

    1 trial

  7. Fimasartan

    Yung

    Essential Hypertension

    phase 1 small molecule completed

    1 trial

  8. Fimasartan/Atorvastatin Combination Tablet

    Yung

    Hypertension

    phase 1 small molecule completed

    1 trial

  9. Rabeprazole Sodium 10mg

    Yung

    Gastroesophageal Reflux Disease

    phase 1 small molecule completed

    1 trial

  10. Pregabalin

    Yung

    Diabetic Peripheral Neuropathy

    approved small molecule completed

    1 trial

Frequently asked questions

What is Yung?

Yung (C2ABC21) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Yung sponsor?

We track 10 ClinicalTrials.gov-linked programs for Yung, including Fimasartan and Rosuvastatin and 9 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Yung company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.